Overview
Misty Shields is a primary care provider, practicing in Internal Medicine in Indianapolis, Indiana. Dr. Shields has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer. Dr. Shields is currently accepting new patients.
Her clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Hemolysis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MANAGED MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICAID
- STATE MEDICAID
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
535 Barnhill Dr, Indianapolis, IN 46202
1701 N Senate Blvd, Indianapolis, IN 46202
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Family Physicians, Inc.
Rajesh Kumar is a primary care provider, practicing in Internal Medicine in Indianapolis, Indiana. Dr. Kumar is rated as a Distinguished provider by MediFind in the treatment of Hemolysis. His top areas of expertise are Asthma, Heart Failure, Type 2 Diabetes (T2D), Iridectomy, and Gallbladder Removal. Dr. Kumar is currently accepting new patients.
Indiana Blood And Marrow Transplantation LLC
Waled Bahaj is a primary care provider, practicing in Internal Medicine in Indianapolis, Indiana. Dr. Bahaj is rated as an Advanced provider by MediFind in the treatment of Hemolysis. His top areas of expertise are Idiopathic Neutropenia, Agranulocytosis, Paroxysmal Cold Hemoglobinuria, Tissue Biopsy, and Splenectomy. Dr. Bahaj is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Shields isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Shields isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Shields isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Shields isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Dubin-Johnson SyndromeDr. Shields isAdvanced. Learn about Dubin-Johnson Syndrome.
- EGFR Positive Lung CancerDr. Shields isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaDr. Shields isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Shields isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Adult T-Cell LeukemiaDr. Shields isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Shields isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Shields isExperienced. Learn about Anemia.
- Chronic Familial NeutropeniaDr. Shields isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic T-Cell Leukemia (CTCL)Dr. Shields isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).